澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

ADALTA LTD

0.005

0.000

成交量：100.20万

成交额：5,010.00

市值：1,274.83万

市盈率：-0.07

高：0.005

开：0.005

低：0.005

收：0.005

52周最高：0.160

52周最低：0.003

股本：25.50亿

流通股本：7,579.14万

量比：2.64

换手率：1.32%

股息：- -

股息率：- -

每股收益(TTM):-0.069

每股收益(LYR):-0.069

净资产收益率：-628.72%

总资产收益率：-72.30%

市净率：-21.31

市盈率(LYR):-0.07

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Adalta与上海细胞治疗集团达成协议共同开发Bzds1901大中华区以外全球市场

Adalta撤回2025年股东大会上关于股份合并的第六项决议

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/1AD.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"1AD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AD.AU\",,,,,undefined,":{"symbol":"1AD.AU","market":"AU","secType":"STK","nameCN":"ADALTA LTD","latestPrice":0.005,"timestamp":1770678265479,"preClose":0.005,"halted":0,"volume":1001963,"delay":0,"changeRate":0,"nameEN":"ADALTA LTD","floatShares":75791359,"shares":2549669000,"eps":-0.068999,"marketStatus":"交易中","change":0,"latestTime":"02-10 12:37:18 AEDT","open":0.005,"high":0.005,"low":0.005,"amount":5010,"amplitude":0,"askPrice":0.005,"askSize":11840114,"bidPrice":0.004,"bidSize":28863037,"shortable":3,"etf":0,"ttmEps":-0.068999,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.005,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":2.643613,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AD.AU\",,,,,undefined,":{"symbol":"1AD.AU","floatShares":75791359,"roa":"-72.30%","roe":"-628.72%","lyrEps":-0.068939,"volumeRatio":2.643613,"shares":2549669000,"dividePrice":0,"high":0.005,"amplitude":0,"preClose":0.005,"low":0.005,"week52Low":0.003,"pbRate":"-21.31","psRate":"18.83","week52High":0.16,"institutionHeld":0,"latestPrice":0.005,"committee":0.418221,"eps":-0.068999,"divideRate":0,"volume":1001963,"delay":0,"ttmEps":-0.068999,"open":0.005,"prevYearClose":0.003,"prevWeekClose":0.004,"prevMonthClose":0.005,"prevQuarterClose":0.003,"fiveDayClose":0.004,"twentyDayClose":0.006,"sixtyDayClose":0.04,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/1AD.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-12-09","symbol":"1AD.AU","defaultRemindTime":1765234800000,"type":"split","dateTimestamp":1765198800000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"AU","date":"2021-12-17","symbol":"1AD.AU","defaultRemindTime":1639695600000,"type":"split","dateTimestamp":1639659600000,"forFactor":990277,"toFactor":1000000,"ratio":0.990277},{"market":"AU","date":"2020-08-13","symbol":"1AD.AU","defaultRemindTime":1597276800000,"type":"split","dateTimestamp":1597240800000,"forFactor":981818,"toFactor":1000000,"ratio":0.981818}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"1AD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"1AD.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1175535273","title":"Adalta与上海细胞治疗集团达成协议 共同开发Bzds1901大中华区以外全球市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1175535273","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175535273?lang=zh_cn&edition=fundamental","pubTime":"2026-01-02 06:21","pubTimestamp":1767306079,"startTime":"0","endTime":"0","summary":"Adalta有限公司宣布与上海细胞治疗集团签署合作协议，双方将共同开发创新药物Bzds1901。根据协议条款，Adalta将获得该药物在大中华区（包括中国大陆、香港、澳门和台湾）以外所有全球市场的独家开发和商业化权利。此次合作标志着Adalta在拓展全球细胞治疗市场方面迈出重要一步，也为Bzds1901的国际化布局奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AD.AU"],"gpt_icon":0},{"id":"1160290721","title":"Adalta撤回2025年股东大会上关于股份合并的第六项决议","url":"https://stock-news.laohu8.com/highlight/detail?id=1160290721","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160290721?lang=zh_cn&edition=fundamental","pubTime":"2025-11-20 01:04","pubTimestamp":1763571893,"startTime":"0","endTime":"0","summary":"11月7日——Adalta Ltd宣布：*关于提议的股份合并的第六项决议已从2025年股东大会中撤回*更多公司动态：1AD.AX*","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["1AD.AU","BK7067"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/1AD.AU\",params:#limit:6,delay:true,,,undefined,":[]}}